Alinsub, Jan Rylle .

HRN: 26-18-26  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2024
CEFUROXIME 1.5GM (VIAL)
11/06/2024
11/13/2024
IV
550mg
Q8h
PCAP-C
Waiting Final Action 
11/06/2024
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
11/06/2024
11/11/2024
PO
4ml
OD
PCAP-C
Waiting Final Action 
11/11/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
11/11/2024
11/18/2024
PO
6.5ml
BID
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: